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1. Introduction 
The Thy-l molecule (formerly called theta) is the 
major membrane antigen of mouse and rat thymocytes 
[ 1,2]. Large amounts are also found in brain tissue of 
these species and to a lesser extent on bone marrow 
cells of the rat, but not of the mouse [3]. On the 
other hand, Thy-l antigen is expressed on peripheral 
T-lymphocytes only of the mouse [4] and is widely 
used for serological differentiation of T- and B-lym- 
phocytes of the mouse. Following neonatal thymectomy 
a dramatic decrease of the proportion of Thy-l 
positive peripheral lymphocytes is observed together 
with a decrease in cell-mediated immunity [5]. 
Furthermore physiological maturation of potential 
T-lymphocytes by passage through the thymus, a 
process which might depend on soluble thymic fac- 
tors, can be followed by appearance of Thy-l antigen 
[6]. Despite the obvious importance of this molecule, 
little is known of the chemical nature of mouse 
Thy-l which is still a matter of controversy [7]. 
In the rat, Thy-l has been described as a glyco- 
protein with mol. wt 18 000 [8], and it seems likely 
that the corresponding molecule of the mouse is of 
similar nature [7]. 
The function of Thy-l is still unclear but a 
possible role in cell-cell interactions, involving the 
carbohydrate part, has been discussed. Antisera with 
specificity for Thy-l antigen do not necessarily 
detect differences in carbohydrate constitutents of 
glycoproteins. By use of lectins, with defined specific- 
ity for different sugar derivatives, heterogeneity in 
the carbohydrate part of Thy-l from rat has been 
found [9]. Mouse Thy-l has not, so far, been shown 
to reveal such diversity. The possible existence of Thy-l 
heterogeneity of mouse thymocytes is challenging 
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and might have functional implications. This paper 
describes such a heterogeneity. 
2. Materials and methods 
2 .l . Cell and Thy-I preparation 
Thymus glands from 2-4 month old C57BL mice 
(expressing Thy-l .2 antigen) were used as the source 
of thymocytes. Cells were washed twice in Hank’s 
medium and lysed in 0.1 M Tris-HCl buffer (pH 8.0) 
containing 0.5% Na-deoxycholate. This concentration 
of detergent has been found not to interfere with 
the assay for quantitative determination of Thy-l 
[lo]. The sample (corresponding to -40 X 1 O6 cells/ 
ml) was sonicated twice for 60 s at +4”C and left for 
1 h at +4”C with slight agitation. After centrifugation 
50 min at 100 000 X g the supernatant was collected. 
2.2.Antiserum 
The antiserum was raised in rabbits against mouse 
brain homogenate [ 1 I] and was shown to be specific 
for Thy-l after appropriate absorption [lo]. 
2.3. Thy-1 assay 
Thy-l was quantitated as in [lo]. Briefly, the 
material to be assayed was diluted in ‘log dilutions 
in Hanks’ medium complemented with 10% bovine 
serum albumin. After addition of antiserum the 
mixture was incubated at +4”C for 1 h. The amount 
of anti-Thy-l antibodies consumed was measured 
by adding guinea pig serum as source of complement 
and 51Cr-labelled thymocytes. The mixture was 
incubated for 1 h at 37°C. The antigen dilution 
giving 50% lysis was used as a measure of antigen 
activity. 
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2.4. Lectin gels 
Lentil lectin-Sepharose 4B (2 mg lentil/mg gel) 
and concanavalin A-Sepharose 4B (10 mg con A/mg 
gel) were purchased from Pharmacia, Sweden. Pasteur 
pipettes were used as columns, and filled with 0.5 ml 
gel. Before use, each gel was washed with lo-20 vol. 
of 0.5% Nadeoxycholate in 0.1 M Tris-HCl buffer 
(pH 8 .O). After sample application, unbound material 
was washed out with the same buffer. The bound 
fraction was eluted with 0.5 M a-methyl-D-mannoside 
in deoxycholate buffer. 
3. Results 
3 .l . Binding to lentil lectin 
An aliquot of the cell preparation (corresponding 
to 1.6 X 10s thymocytes) was applied to the lentil 
lectin-Sepharose 4B column and washed with 
5-6 vol. buffer. Bound material was eluted with 
cw-methyl-D-mannoside. Fractions were collected and 
assayed for Thy-l activity. As shown (fig.la) one 
population of Thy-l molecules passed through the 
column unbound, while another population was 
bound and specifically eluted with sugar. The amount 
of Thy-l antigen was about the same in the two peaks. 
To exclude the possibility of overloading the column, 
each population was pooled and dialyzed against 
deoxycholate buffer overnight and rechromatography 
was performed on new gels under the same conditions 
as above (fig.lb ,c). It was shown that the two pooled 
fractions performed in the same way as in the first 
run. The pooled fraction A was again unbound and 
fraction B was completely bound and eluted. 
3.2. Binding to Con A 
The binding of Thy-l antigen to con A was carried 
out in the same way as above. In contrast to lentil 
lectin all Thy-l was bound to con A, but only a 
fraction of the bound material (-30%) could be eluted 
with cu-methyl-D-mannoside, probably due to strong 
interaction of Thy-l with con A. 
4. Discussion 
Here study heterogeneity in the carbohydrate part 
of Thy-l molecules from mouse thymocytes is shown 
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Fig.1 .Affinity chromatography onlentillectin-Sepharose4B: 
(a) thymocyte extract (3.5 ml sample); (b) pooled fraction A 
from expt a (4.5 ml sample); (c) pooled fraction B from 
expt a (5.5 ml sample). Fractions of 0.5 ml were collected 
and assayed for Thy-l activity, which is expressed as percent 
of the total applied activity. &MM, o-methyl-D-mannoside 
(0.5 M) in deoxycholate buffer. 
for the first time. These cells possess at least two popu- 
lations of Thy-l molecules, one which has affinity for 
lentil lectin and one which has not. The difference 
between the two forms of Thy-l can not be detected 
by any antisera used [ 1 ,12-l 61 and it is suggested 
that the antigenic determinants exist on the protein 
part ofthemolecule [17].However,in [18] two 
antigenic specificities of mouse Thy-l were demon- 
strated by use of rat anti-Thy-l .l xenoantiserum. 
Whether these antigenic determinants are related to 
the protein or the carbohydrate part is still unclear. 
Preliminary results show that the two forms 
described here are of about the same size, as judged 
by SDS-polyacrylamide gel electrophoresis [IO]. 
Using a T-cell lymphoblastoid cell line, a homoge- 
neous Thy-l population has been shown that binds 
to lentil lectin [ 191. Whether the two forms of the 
Thy-l molecules now demonstrated exist on the 
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same or different cells is yet to be elucidated. Both 
for cell differentiation within one ceil line and/or 
discrim~ation between subpopulations of thymo- 
cytes a heterogeneity of Thy-l might be of impor- 
tance. Interestingly, the Thy-l antigenic specificities 
reported [ 181 were identified on different sub- 
populations of peripheral T-lymphocytes and 
reflected a maturation process rather than a func- 
tional diversity. 
The amount of the two forms of Thy-l antigen 
described here was about equal, an observation which 
is in agreement with the findings in [93 for rat 
thymocytes. This observation indicates similarities 
between rat and mouse Thy-l of thymocytes. 
~oncanavalin A and lentil lectin usually are con- 
sidered to possess imilar sugar specificity [ZO]. In 
the present investigation differences in binding 
pattern however were observed since con A was able 
to absorb all Thy-l antigen activity from the thymo- 
cyte extract. 
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